Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief. - Test2 - elhamkhani - TriplyDB

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

http://www.wikidata.org/entity/Q37362037

about

Pigmy MicroRNA: surveillance cops in Therapies kingdom Molecular and cellular mechanisms that initiate pain and itch.Injury-induced maladaptation and dysregulation of calcium channel α2 δ subunit proteins and its contribution to neuropathic pain development.Challenges to develop novel anti-inflammatory and analgesic drugs.Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.Breaking barriers to novel analgesic drug development.Nanosecond electric pulses differentially affect inward and outward currents in patch clamped adrenal chromaffin cells.Electrophysiological evidence for voltage-gated calcium channel 2 (Cav2) modulation of mechano- and thermosensitive spinal neuronal responses in a rat model of osteoarthritis.Possible involvement of transient receptor potential ankyrin 1 in Ca2+ signaling via T-type Ca2+ channel in mouse sensory neurons.Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1.Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain.A 3D structural model of RsXXVIA, an ω-conotoxin

P2860

Q28818470-6F5D1C19-8984-44EE-82A5-D7A14A094A4F Q35946504-C37BD4B2-2EDF-48A2-8E8E-FEC52F38A42A Q38711009-032BC033-7A32-460A-88EC-15B4B6F9C1C6 Q38941483-6CCAF171-2A2D-4D9B-A0B0-E35BFE58A683 Q39141992-AC514AC2-0997-4531-ACC3-B831E0962A66 Q39360773-00729FB0-2CED-4F1B-A3F9-B9D554D98DC8 Q40994466-A394CDBD-8412-40A6-98FC-37BE69FCEE29 Q41875833-4089FC7E-6D98-4DF7-A8F4-3958D70B9587 Q47240731-5EA0386E-E707-4214-9DA0-5A7F485311FF Q48286804-28F27716-21C4-4DF6-B2A1-79BD66D7E8DD Q52310350-48934DA0-3ED0-4893-B3D9-EC633E791DC6 Q58664956-6FE0CE94-6346-4DB3-B97C-2F0D10A371B3

P2860

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

http://www.wikidata.org/entity/Q37362037

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacological Inhibition of Voltage-gated Ca

@nl

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

@en

type

label

Pharmacological Inhibition of Voltage-gated Ca

@nl

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

@en

prefLabel

Pharmacological Inhibition of Voltage-gated Ca

@nl

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

@en

P1433

Q37362037-9D251377-33BE-4A74-B882-6490E568FE19

P1476

Q37362037-F337D9B7-37A9-401E-A9E6-401F387549BF

P2093

Q37362037-D212147E-0048-45E0-8AD3-80F5333A125E

P2860

Q37362037-023A4C90-1D71-47F3-8A69-D07B6536B0A0

Q37362037-04AC9EB0-D19E-42C8-BCBB-5227C0ADCBA2

Q37362037-0744F2AF-F31D-46E0-9127-A7BFD406E210

Q37362037-07605A58-7F61-413E-8144-E40B06CC9D54

Q37362037-084286B8-63DC-49D9-B960-9E7D6D1C9DAE

Q37362037-0B306CB7-EC77-4D90-A246-4FB38943250F

Q37362037-0BFF886E-594F-4CB1-AAEC-8F3B260755C5

Q37362037-0C350D4B-D422-447F-9508-983B89E9356E

Q37362037-0D329962-ED94-49F4-BB20-C4527F7C54E9

Q37362037-0DBDE81D-27EA-4DD0-9808-C8D9C5C48729

P304

Q37362037-D0E6BBBA-234B-4E37-BBB8-ADDBAC0BEBD0

P31

Q37362037-A4C71725-C1C5-477E-BB27-BB2F93B181AC

P356

Q37362037-A4119C81-22D6-4A28-B636-4FFE8B8FFEA5

P433

Q37362037-9FAF11FA-53F1-4DD2-88F0-77EF7B2E1058

P478

Q37362037-2A6AB83E-8FE2-4935-8704-27D81C00DD3F

P577

Q37362037-330E9BAE-1A5F-42E9-AB85-6D2E2449AE16

P5875

Q37362037-842998D7-75FC-4AEF-90D8-6F056F4413D8

P698

Q37362037-4E214655-9F40-42B5-9192-447CA4538917

P921

Q37362037-0AFB6A9B-0253-4988-A925-000D9C24FA5E

Q37362037-22B51D22-28B5-46D1-9521-1AC6279D378F

P932

Q37362037-28AB42E7-2BAB-4853-B0E5-CD1B9ED4DEB6

P356

1570159X11311060005

P1433

Current Neuropharmacology

P1476

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.

@en

P2093

Seungkyu Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation

Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain

A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene.

Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin

Ziconotide: a review of its pharmacology and use in the treatment of pain

Control of low-threshold exocytosis by T-type calcium channels

T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome

Voltage-gated calcium channels

Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels

P304

606-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570159X11311060005

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259608646

http://www.w3.org/2001/XMLSchema#string

P698

24396337

http://www.w3.org/2001/XMLSchema#string

P921

P932

3849787

http://www.w3.org/2001/XMLSchema#string